Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update Journal Article
| Authors: | Kris, M. G.; Manegold, C. |
| Article Title: | Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update |
| Abstract: | Based on the results of two recent trials, docetaxel (Taxotere; Aventis, Antony, France) is now the drug of choice for the treatment of advanced non-small cell lung cancer that is refractory to primary chemotherapy. Trials are testing the role of docetaxel in the induction setting, as well as concomitantly with radiation therapy. Copyright © 2001 by W.B. Saunders Company. |
| Keywords: | cancer survival; clinical trial; neutropenia; review; cisplatin; advanced cancer; multimodality cancer therapy; gemcitabine; paclitaxel; cancer radiotherapy; quality of life; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; antineoplastic agents, phytogenic; docetaxel; drug response; taxoids; molecular biology; radiation-sensitizing agents; clinical trials; drug choice; humans; human; priority journal |
| Journal Title: | Seminars in Oncology |
| Volume: | 28 |
| Issue: | Suppl. 2 |
| ISSN: | 0093-7754 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2001-02-01 |
| Start Page: | 1 |
| End Page: | 3 |
| Language: | English |
| PUBMED: | 11284618 |
| PROVIDER: | scopus |
| DOI: | 10.1016/S0093-7754(01)90296-9 |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
